Literature DB >> 20505495

Ongoing changes in HIV RNA levels during untreated HIV infection: implications for CD4 cell count depletion.

Andrew N Phillips1, Fiona C Lampe, Colette J Smith, Anna-Maria Geretti, Alison Rodger, Rebecca K Lodwick, Valentina Cambiano, Robert Tsintas, Margaret A Johnson.   

Abstract

BACKGROUND: Understanding of the interplay between plasma HIV RNA level and CD4 cell count depletion in untreated infection remains incomplete.
METHODS: We studied 1169 people with HIV seen for care at a major London clinic while naive to antiretroviral therapy. We considered pairs (n = 5940) of consecutive simultaneously measured CD4 cell count and plasma HIV RNA values from patients who had never started therapy. Baseline was the first date when both measures were known.
RESULTS: HIV RNA levels increased variably and often substantially from baseline (60% experience an increase of over 50 000 copies/ml by 5 years of follow-up). The current HIV RNA level (i.e. first value of the pair) was strongly associated with the time-standardized change in CD4 cell count, with a mean 106 cells/microl per year greater rate of CD4 cell count decline per log-copy/ml higher current HIV RNA level (P < 0.0001). After adjustment for the current level, higher baseline HIV RNA was not associated with CD4 cell count decline. There was no average CD4 cell count decline with current HIV RNA level below 3.0 log-copies/ml, compared with a 159 cells/microl per year decline for those with HIV RNA at least 5.5 log-copies/ml (P < 0.0001). Further, the current CD4 cell count predicted subsequent changes in HIV RNA level (0.04 log-copies/year greater increases per 100 cells/microl lower CD4 cell count; P < 0.0001).
CONCLUSION: The often substantial increases in HIV RNA level observed in untreated HIV infection appear fundamentally linked to CD4 cell count depletion. Research into mechanisms by which HIV RNA levels rise over time should yield insights into the causes of CD4 cell count depletion, as the two processes are intimately linked.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20505495     DOI: 10.1097/QAD.0b013e32833a6056

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  10 in total

1.  The interplay between CD4 cell count, viral load suppression and duration of antiretroviral therapy on mortality in a resource-limited setting.

Authors:  Alana T Brennan; Mhairi Maskew; Ian Sanne; Matthew P Fox
Journal:  Trop Med Int Health       Date:  2013-02-18       Impact factor: 2.622

2.  Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome.

Authors:  Cynthia L Monaco; David B Gootenberg; Guoyan Zhao; Scott A Handley; Musie S Ghebremichael; Efrem S Lim; Alex Lankowski; Megan T Baldridge; Craig B Wilen; Meaghan Flagg; Jason M Norman; Brian C Keller; Jesús Mario Luévano; David Wang; Yap Boum; Jeffrey N Martin; Peter W Hunt; David R Bangsberg; Mark J Siedner; Douglas S Kwon; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2016-03-09       Impact factor: 21.023

3.  Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients.

Authors:  Aubin J Nanfack; Andrew D Redd; Jude S Bimela; Genesis Ncham; Emmanuel Achem; Andrew N Banin; Allison R Kirkpatrick; Stephen F Porcella; Lucy A Agyingi; Josephine Meli; Vittorio Colizzi; Arthur Nádas; Miroslaw K Gorny; Phillipe N Nyambi; Thomas C Quinn; Ralf Duerr
Journal:  J Clin Microbiol       Date:  2017-06-28       Impact factor: 5.948

4.  CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7.

Authors:  Marta Catalfamo; Christopher Wilhelm; Lueng Tcheung; Michael Proschan; Travis Friesen; Jung-Hyun Park; Joseph Adelsberger; Michael Baseler; Frank Maldarelli; Richard Davey; Gregg Roby; Catherine Rehm; Clifford Lane
Journal:  J Immunol       Date:  2011-01-21       Impact factor: 5.422

5.  Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy.

Authors:  Michael J Mugavero; Sonia Napravnik; Stephen R Cole; Joseph J Eron; Bryan Lau; Heidi M Crane; Mari M Kitahata; James H Willig; Richard D Moore; Steven G Deeks; Michael S Saag
Journal:  Clin Infect Dis       Date:  2011-09-02       Impact factor: 9.079

6.  Plasma Cytokine Levels in Chronic Asymptomatic HIV-1 Subtype C Infection as an Indicator of Disease Progression in Botswana: A Retrospective Case Control Study.

Authors:  Thato Iketleng; Sikhulile Moyo; Simani Gaseitsiwe; Balthazar Nyombi; Rebecca M Mitchell; Joseph Makhema; Marianna K Baum; Richard Marlink; Max Essex; Rosemary Musonda
Journal:  AIDS Res Hum Retroviruses       Date:  2015-10-21       Impact factor: 2.205

7.  Factors associated with short-term changes in HIV viral load and CD4(+) cell count in antiretroviral-naive individuals.

Authors: 
Journal:  AIDS       Date:  2014-06-01       Impact factor: 4.177

8.  APOL1 Renal Risk Variants and Kidney Function in HIV-1-Infected People From Sub-Saharan Africa.

Authors:  Nongodo Firmin Kabore; Amandine Cournil; Armel Poda; Laura Ciaffi; Elizabeth Binns-Roemer; Victor David; Sabrina Eymard-Duvernay; Jacques Zoungrana; Aoua Semde; Adrien B Sawadogo; Sinata Koulla-Shiro; Charles Kouanfack; Ndeye Fatou Ngom-Gueye; Nicolas Meda; Cheryl Winkler; Sophie Limou
Journal:  Kidney Int Rep       Date:  2021-10-16

9.  Cascade of HIV care and population viral suppression in a high-burden region of Kenya.

Authors:  David Maman; Clement Zeh; Irene Mukui; Beatrice Kirubi; Sophie Masson; Valarie Opolo; Elisabeth Szumilin; Benjamin Riche; Jean-François Etard
Journal:  AIDS       Date:  2015-07-31       Impact factor: 4.177

10.  HIV and development of epithelial cell abnormalities in women with prior normal cervical cytology in Nigeria.

Authors:  Jonah Musa; Supriya D Mehta; Chad J Achenbach; Charlesnika T Evans; Neil Jordan; Francis A Magaji; Victor C Pam; Patrick H Daru; Olugbenga A Silas; Atiene S Sagay; Rose Anorlu; Yinan Zheng; Mamoudou Maiga; Isaac F Adewole; Robert L Murphy; Lifang Hou; Melissa A Simon
Journal:  Infect Agent Cancer       Date:  2020-07-29       Impact factor: 2.965

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.